[1]

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, et al. 2024. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal For Clinicians 74:229−63

doi: 10.3322/caac.21834
[2]

Riihimäki M, Hemminki A, Sundquist K, Sundquist J, Hemminki K. 2016. Metastatic spread in patients with gastric cancer. Oncotarget 7:52307−16

doi: 10.18632/oncotarget.10740
[3]

Mazur MT, Hsueh S, Gersell DJ. 1984. Metastases to the female genital tract. Analysis of 325 cases. Cancer 53:1978−84

doi: 10.1002/1097-0142(19840501)53:9<1978::AID-CNCR2820530929>3.0.CO;2-1
[4]

Peng Z, Fang C, Tong Z, Rao Q, Ren Z, et al. 2024. Crosstalk between cancer-associated fibroblasts and myeloid cells shapes the heterogeneous microenvironment of gastric cancer. Current Genomics 25:390−411

doi: 10.2174/0113892029300608240531111743
[5]

Matsushita H, Watanabe K, Wakatsuki A. 2016. Metastatic gastric cancer to the female genital tract. Molecular and Clinical Oncology 5:495−99

doi: 10.3892/mco.2016.1035
[6]

McCluggage WG, Hurrell DP, Kennedy K. 2010. Metastatic carcinomas in the cervix mimicking primary cervical adenocarcinoma and adenocarcinoma in situ: report of a series of cases. The American Journal of Surgical Pathology 34:735−41

doi: 10.1097/PAS.0b013e3181d6b8fd
[7]

Kumar NB, Hart WR. 1982. Metastases to the uterine corpus from extragenital cancers. A clinicopathologic study of 63 cases. Cancer 50:2163−69

doi: 10.1002/1097-0142(19821115)50:10<2163::AID-CNCR2820501032>3.0.CO;2-F
[8]

Liu D, Lu M, Li J, Yang Z, Feng Q, et al. 2016. The patterns and timing of recurrence after curative resection for gastric cancer in China. World Journal of Surgical Oncology 14:305

doi: 10.1186/s12957-016-1042-y
[9]

Jiao X, Wang Y, Wang F, Wang X. 2020. Recurrence pattern and its predictors for advanced gastric cancer after total gastrectomy. Medicine 99:e23795

doi: 10.1097/MD.0000000000023795
[10]

Imachi M, Tsukamoto N, Amagase H, Shigematsu T, Amada S, et al. 1993. Metastatic adenocarcinoma to the uterine cervix from gastric cancer. A clinicopathologic analysis of 16 cases. Cancer 71:3472−77

doi: 10.1002/1097-0142(19930601)71:11<3472::AID-CNCR2820711103>3.0.CO;2-V
[11]

Martínez-Román S, Frumovitz M, Deavers MT, Ramirez PT. 2005. Metastatic carcinoma of the gallbladder mimicking an advanced cervical carcinoma. Gynecologic Oncology 97:942−45

doi: 10.1016/j.ygyno.2005.01.054
[12]

Pérez-Montiel D, Serrano-Olvera A, Salazar LC, Cetina-Pérez L, Candelaria M, et al. 2012. Adenocarcinoma metastatic to the uterine cervix: a case series. The Journal of Obstetrics and Gynaecology Research 38:541−49

doi: 10.1111/j.1447-0756.2011.01747.x
[13]

Suyila Q, Li X, Su X. 2025. Anti-cancer bioactive peptide induces apoptosis in gastric cancer cells through TP53 signaling cascade. Protein and Peptide Letters 32:194−205

doi: 10.2174/0109298665350654250111144722
[14]

Raspollini MR, Baroni G, Taddei A, Taddei GL. 2003. Primary cervical adenocarcinoma with intestinal differentiation and colonic carcinoma metastatic to cervix: an investigation using Cdx-2 and a limited immunohistochemical panel. Archives of Pathology & Laboratory Medicine 127:1586−90

doi: 10.5858/2003-127-1586-PCAWID
[15]

Wang K, Yu Y, Zhao J, Meng Q, Xu C, et al. 2024. A retrospective analysis of the Lauren classification in the choice of XELOX or SOX as an adjuvant chemotherapy for gastric cancer. Current Gene Therapy 24:147−58

doi: 10.2174/0115665232247694230921060213
[16]

Li Q, Chu Y, Yao Y, Song Q. 2024. FAT4 mutation is related to tumor mutation burden and favorable prognosis in gastric cancer. Current Genomics 25:380−89

doi: 10.2174/0113892029300694240612081006
[17]

Zhang M, Li K, Yin R. 2022. Gastric cancer in a 22-year-old woman with metastasis to the cervix: a case report and literature review. Gynecology and Pelvic Medicine 5:21

doi: 10.21037/gpm-21-32